Literature DB >> 21951858

Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation.

Nicoletta Riva, Danielle E Smith, Gregory Y H Lip, Deirdre A Lane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21951858     DOI： 10.1093/ageing/afr128

Source DB:  PubMed          Journal:  Age Ageing        ISSN： 0002-0729            Impact factor:   10.668


× No keyword cloud information.
  2 in total

1.  Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.

Authors:  Yishen Wang; Beata Bajorek
Journal:  Int J Clin Pharm       Date:  2016-06-10

2.  Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.

Authors:  Tim A Holt; David A Fitzmaurice; Tom Marshall; Matthew Fay; Nadeem Qureshi; Andrew R H Dalton; F D Richard Hobbs; Daniel S Lasserson; Karen Kearley; Jenny Hislop; Jing Jin
Journal:  Trials       Date:  2013-11-13       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.